Showing results (1311-1320 of 15,790) with videos related to

Sort By:
Pageof 1,579
European Journal of Immunology|May 19, 2011
B lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cellsMarzena Ciechomska, Thomas W J Lennard, John A Kirby, et al.
European Journal of Immunology|June 2, 2011
The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cellsHervé Luche, Laurence Ardouin, Pearline Teo, et al.
European Journal of Immunology|April 22, 2011
Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosisFinlay W McNab, Matthew P R Berry, Christine M Graham, et al.
European Journal of Immunology|April 12, 2011
Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rollingAnika Stadtmann, Laura Brinkhaus, Helena Mueller, et al.
European Journal of Immunology|April 12, 2011
Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophagesSenthil Palani, Mikael Maksimow, Mari Miiluniemi, et al.
European Journal of Immunology|April 12, 2011
Recognition of yeast nucleic acids triggers a host-protective type I interferon responseCarmelo Biondo, Giacomo Signorino, Alessandro Costa, et al.
European Journal of Immunology|May 4, 2011
The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cellsPetra Henning, Tobias Gustafsson, Carl-Fredrik Flach, et al.
European Journal of Immunology|May 4, 2011
Generation of a Listeria vaccine strain by enhanced caspase-1 activationSarah E Warren, Hien Duong, Dat Phat Mao, et al.
European Journal of Immunology|May 4, 2011
Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunitySophie R Sierro, Alena Donda, Rachel Perret, et al.
European Journal of Immunology|May 4, 2011
NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibodyVitaly Ablamunits, Octavian Henegariu, Paula Preston-Hurlburt, et al.
Pageof 1,579